by Jessica Etheridge | Jan 22, 2016 | Products & Pipeline, Research & Development
The goal of this study was to analyze case study data that suggests the value of adding CA11-19 to monitoring patients at risk of recurrence of colorectal cancer. Download The...
by Jessica Etheridge | Sep 1, 2015 | Research & Development
Knoxville, Tenn. – (August 31, 2015) – EDP Biotech Corporation, (EDP), a global in vitro diagnostic innovator of simple, blood-based cancer diagnostic tests, announces the publication of key study data for its ColoMarkerÒ ELISA kit. In this clinical research study,...
by Jessica Etheridge | Jul 10, 2015 | Products & Pipeline, Research & Development
The primary objective of this study was to determine the correlation between elevated levels of the CA 11-19 tumor marker in blood and the presence of colorectal cancer or pre-cancer. Download the Study
by Jessica Etheridge | Apr 14, 2014 | Research & Development
ASCO 50th Annual Meeting Abstract – Poster Session Gastroenterology Colon Cancer Session May 31, 2014 8am-11am McCormick Place – Chicago, IL
by Jessica Etheridge | Jan 14, 2014 | Products & Pipeline, Research & Development
Passion, perseverance behind the development of ColoMarker® Knox Focus At 75 years old, Tommye Jordan is a quick witted, energetic grandmother; dressed unassumingly in a festive holiday sweater…. She is also responsible for ColoMarker®- a groundbreaking medical...
by Jessica Etheridge | Jul 9, 2013 | Research & Development
ColoMarker®: convenient, low-cost, early stage colon cancer blood test reports validation EDP Biotech announces path to commercialization, prepares to go global KNOXVILLE, Tenn.–(BUSINESS WIRE)-July 9th, 2013-EDP Biotech, the US-based developer of a blood test...
